Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novimmune SA

www.novimmune.com

Latest From Novimmune SA

Sobi Targets Thrombocytopenia In $915m Swoop For Dova

The Swedish group has got hold of the ITP and CLD drug Doptelet, widening its hematology business beyond hemophilia.

M & A Blood & Coagulation Disorders

AstraZeneca Buys Priority Review Voucher With Two Big Filings On The Horizon

AstraZeneca paid $95m to Swedish Orphan Biovitrum for the voucher, which it could use to expedite the FDA review of roxadustat or trastuzumab deruxtecan.

Drug Review Launches

Novimmune Sells Gamifant And IO Assets To Sobi

Swiss biotech Novimmune SA creates newco around Gamifant emapalumab and other immuno-oncology assets and then sells it to Sobi for CHF515m ($519.2m).
Commercial ImmunoOncology

Sobi Realigns Focus On Late-Stage Hematology & Immunology Assets

Swedish specialty pharma and rare diseases company seeks to sustain recent rapid revenues growth with increased R&D focus and investments in its hematology and immunology franchises.

BioPharmaceutical Immune Disorders
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • NovImmune SA
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Novimmune SA
  • Senior Management
  • Erik Trock-Jansen, CEO
    Sven Zimmermann, CFO
    Adrian Mills, CBO
    Cristina de Min , MD, CMO
  • Contact Info
  • Novimmune SA
    Phone: (41) 22 839 71 41
    14 Chemin des Aulx
    Plan-Les-Ouates
    Geneva, 1228
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register